Market Cap 19.18M
Revenue (ttm) 970,000.00
Net Income (ttm) -10.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,129.90%
Debt to Equity Ratio -0.01
Volume 40,800
Avg Vol 19,312
Day's Range N/A - N/A
Shares Out 24.27M
Stochastic %K 89%
Beta 0.84
Analysts Strong Buy
Price Target $7.00

Company Profile

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

Industry: Medical Devices
Sector: Healthcare
Phone: 952 405 6216
Address:
5151 Edina Industrial Boulevard, Suite 575, Edina, United States
Elephanthunter7
Elephanthunter7 Jul. 4 at 2:24 PM
$PETV Very impressive board member for a micro cap company. Significantly bolstered the company’s executive leadership with the appointment of board member, Mike Eldred, as the company’s commercialization and operations advisor. He has brought to the position more than 30 years of executive experience in animal health and the veterinary industry, and has been responsible for advancing product development and driving sales growth. He previously built Dechra Pharmaceutical’s North American subsidiary into one of the fastest growing companies in the industry, with more than 250 employees and annual revenue exceeding $450 million
0 · Reply
investical
investical Jul. 3 at 4:18 PM
$PETV spryng - $1,100,000 sales after 4 years on the market…$1000 injection per joint. Price needs to be $200 to work in small animal. As is, niche equine only.
0 · Reply
HurricaneCapital
HurricaneCapital Jul. 3 at 3:39 PM
$PETV Spryng is a multi patented technology, and it takes time to breakthrough into the market, the catalysts like ability to finance from multiple sources at market valuation, Commonwealth using Spryng in its championship horses,Piezo bio membrane (UConn ) initial studies show regeneration in animals with future human market joint replacement in human market potential . Looking for vertical revenue growth this year , catalysts come first in a breakthrough technology company going to market, followed by vertical revenue growth. At these valuation levels - Bullish
0 · Reply
lookout408
lookout408 Jul. 2 at 4:36 PM
$PETV money pls hold if you do come over pls,
0 · Reply
investical
investical Jul. 2 at 3:50 PM
$PETV Lemminghunter7
0 · Reply
Elephanthunter7
Elephanthunter7 Jul. 2 at 12:42 PM
$PETV Only a moron would think buying a stock at a 25% discount from an insider investing $5 million is a bad idea !!
0 · Reply
investical
investical Jul. 1 at 11:52 PM
$PETV follow one un-named bozo investor, not the actual numbers. Sounds like what lemmings do!
0 · Reply
Elephanthunter7
Elephanthunter7 Jul. 1 at 12:11 PM
$PETV Above market financing says it all ! Closed the remaining $4.4 million purchase option as part of a private placement offering initiated in March 2025 totaling $5 million in equity financing in exchange for five million shares of the company’s Series B convertible preferred stock at $1.00 per share, with a preferred share to a common share on a one-for-one basis
0 · Reply
investical
investical Jul. 1 at 12:05 PM
$PETV $1.1M revenues vs $8.1M in operating loss. If 17% growth continued, it’d take 12+ years to reach break even! Only 1.5 quarters of cash on hand even after recent raise! Yikes!!
0 · Reply
Elephanthunter7
Elephanthunter7 Jul. 1 at 11:15 AM
$PETV Fiscal 2026 Outlook For the full fiscal year ending March 31, 2026, the company anticipates another year of record growth and improving bottom line as it continues to expand the use of its Spryng® with OsteoCushion® Technology as well as other new products offered by its expanded medical therapeutics platform.
0 · Reply
Latest News on PETV
No data available.
Elephanthunter7
Elephanthunter7 Jul. 4 at 2:24 PM
$PETV Very impressive board member for a micro cap company. Significantly bolstered the company’s executive leadership with the appointment of board member, Mike Eldred, as the company’s commercialization and operations advisor. He has brought to the position more than 30 years of executive experience in animal health and the veterinary industry, and has been responsible for advancing product development and driving sales growth. He previously built Dechra Pharmaceutical’s North American subsidiary into one of the fastest growing companies in the industry, with more than 250 employees and annual revenue exceeding $450 million
0 · Reply
investical
investical Jul. 3 at 4:18 PM
$PETV spryng - $1,100,000 sales after 4 years on the market…$1000 injection per joint. Price needs to be $200 to work in small animal. As is, niche equine only.
0 · Reply
HurricaneCapital
HurricaneCapital Jul. 3 at 3:39 PM
$PETV Spryng is a multi patented technology, and it takes time to breakthrough into the market, the catalysts like ability to finance from multiple sources at market valuation, Commonwealth using Spryng in its championship horses,Piezo bio membrane (UConn ) initial studies show regeneration in animals with future human market joint replacement in human market potential . Looking for vertical revenue growth this year , catalysts come first in a breakthrough technology company going to market, followed by vertical revenue growth. At these valuation levels - Bullish
0 · Reply
lookout408
lookout408 Jul. 2 at 4:36 PM
$PETV money pls hold if you do come over pls,
0 · Reply
investical
investical Jul. 2 at 3:50 PM
$PETV Lemminghunter7
0 · Reply
Elephanthunter7
Elephanthunter7 Jul. 2 at 12:42 PM
$PETV Only a moron would think buying a stock at a 25% discount from an insider investing $5 million is a bad idea !!
0 · Reply
investical
investical Jul. 1 at 11:52 PM
$PETV follow one un-named bozo investor, not the actual numbers. Sounds like what lemmings do!
0 · Reply
Elephanthunter7
Elephanthunter7 Jul. 1 at 12:11 PM
$PETV Above market financing says it all ! Closed the remaining $4.4 million purchase option as part of a private placement offering initiated in March 2025 totaling $5 million in equity financing in exchange for five million shares of the company’s Series B convertible preferred stock at $1.00 per share, with a preferred share to a common share on a one-for-one basis
0 · Reply
investical
investical Jul. 1 at 12:05 PM
$PETV $1.1M revenues vs $8.1M in operating loss. If 17% growth continued, it’d take 12+ years to reach break even! Only 1.5 quarters of cash on hand even after recent raise! Yikes!!
0 · Reply
Elephanthunter7
Elephanthunter7 Jul. 1 at 11:15 AM
$PETV Fiscal 2026 Outlook For the full fiscal year ending March 31, 2026, the company anticipates another year of record growth and improving bottom line as it continues to expand the use of its Spryng® with OsteoCushion® Technology as well as other new products offered by its expanded medical therapeutics platform.
0 · Reply
Elephanthunter7
Elephanthunter7 Jul. 1 at 11:11 AM
$PETV Awesome numbers Revenues increased 17% to a record $1.1 million, with the strong growth due to the company continued expansion from the equine market into the larger and faster-growing companion animal market with sales of the company’s lead animal osteoarthritis medical device, Spryng® with OsteoCushion™ Technology.
0 · Reply
investical
investical Jun. 30 at 11:11 PM
$PETV Ugly numbers
0 · Reply
jParkz
jParkz Jun. 30 at 10:00 PM
News PetVivo Reports Fiscal 2025 Results https://marketwirenews.com/news-releases/petvivo-reports-fiscal-2025-results-6442905392622642.html $PETV
0 · Reply
OpenOutcrier
OpenOutcrier Jun. 30 at 12:32 PM
Top Earnings Mon 6/30 Aft: $PETV $PRGS $QMCO . Top Earnings Tu 7/1 Pre: $MSM
0 · Reply
Stocktwits
Stocktwits Jun. 29 at 11:01 PM
🚨 What's Happening Tomorrow — Monday, June 30 ▪ Chicago PMI (Jun) (9:45 AM) ▪ FOMC Member Bostic Speaks (10:00 AM) 📈 Earnings ▪ Pre-Market: $ZCAR ▪ After Hours: $QMCO, $PETV, $PRGS 📺 Stocktwits Shows ▪ Wake Up & Trade with @DekmarTrades (7:30am) ▪ Daily Rip Live (9am) *Times in EDT
0 · Reply
jParkz
jParkz Jun. 27 at 10:00 AM
News Article Expected earnings - PetVivo Holdings Inc. https://marketwirenews.com/news-releases/expected-earnings-petvivo-holdings-inc--6866425813407939.html $PETV
0 · Reply
jParkz
jParkz Jun. 26 at 11:00 PM
News out PetVivo Sets Fiscal Fourth Quarter 2025 Conference Call for Monday, June 30 at 5:00 p.m. ET https://marketwirenews.com/news-releases/petvivo-sets-fiscal-fourth-quarter-2025-conference-c-5104020049275399.html $PETV
0 · Reply
investical
investical Jun. 24 at 6:15 PM
$PETV how do these guys have time to sell with how much time they spend raising capital?
0 · Reply
HurricaneCapital
HurricaneCapital Jun. 20 at 4:29 PM
0 · Reply
Elephanthunter7
Elephanthunter7 Jun. 20 at 1:52 PM
$PETV PETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING MINNEAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for horses, dogs and other companion animals announced today that the Company has recently received Three Million Dollars ($3,000,000) pursuant to a partial exercise of a purchase option (“Purchase Option”) granted to the investor as part of an offering to receive Five Million Dollars ($5,000,000) of equity financing in exchange for Five Million shares of Series B Convertible Preferred Stock (“Shares”) (the “Offering”); pursuant to the Offering, the purchase price for one (1) Share of Series B Convertible Preferred Stock is One Dollar ($1.00)
1 · Reply
investical
investical Jun. 12 at 9:26 PM
$PETV hey elephant man, why the promissory notes if they have this subscription agreement?
0 · Reply
investical
investical Jun. 12 at 3:53 PM
$PETV why does this company keep issuing promissory notes? Someone on this board said they raised $5,000,000. What gives?
0 · Reply